Micro-organisms in your pills up next: scientist
Nascent discoveries give shot in the arm for biotech stocks
[SINGAPORE] The hottest thing in the already-hot biotechnology sector are tiny bugs, so investors should pay attention to the commercialisation of health supplements containing micro-organisms, an American biotech entrepreneur has said.
Stephen Turner, who founded Nasdaq-listed gene sequencing equipment maker Pacific Biosciences, said discoveries are coming thick and fast on the microbiome, that community of bacteria and other micro-organisms residing in the human gut, skin and eyes.
A microbiome supplement, for example, could be invented to aid oral health, working through the introduction of a specific form of bacteria to kick out other disease-causing bacteria.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
New Articles
HDB resale prices accelerate, rising 1.8% in Q1 on stronger demand
Digital Core Reit Q1 distributable income slips 2.4% to US$10.6 million
BT subscribers can now share 5 premium articles a month with unlimited number of non-subscribers
First Reit reports 3.2% lower Q1 DPU of S$0.006 amid interest rate, forex headwinds
Vietnam holds first gold auction in 11 years to stabilise market
How Hudson Yards went from ghost town to office success story